We suppose the possible reasons as follows: 1) 17β-estradiol (E2) increased glucose uptake capacity in an HR-positive breast cancer cell line mediated by ER-dependent activation of PI3K/Akt signaling pathway15,16. This evidence concerns the gene ESR1 and breast cancer.